Carboxypeptidase G2 (CPG2) Inhibitor
Carboxypeptidase G2 (CPG2) Inhibitor is a novel CPG2 inhibitor with an Ki of 0.3 μM. Carboxypeptidase G2 (CPG2) Inhibitor effectively neutralizes the CPG2 activity in non-tumor sites, allowing for earlier administration of the drug and forming a complementary strategy with antibody clearance strategies. Carboxypeptidase G2 (CPG2) Inhibitor can be used for the study of antibody-directed enzyme prodrug therapy (ADEPT) [1].
Product Specifications
CAS Number
192203-60-4
Product Name Alternative
CPG2 Inhibitor
UNSPSC
12352005
Target
Carboxypeptidase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/carboxypeptidase-g2-_cpg2_-inhibitor.html
Purity
98.03
Solubility
10 mM in DMSO|H2O : 1.43 mg/mL (ultrasonic)
Smiles
O=C(SC(C=C1)=CC=C1OC)N[C@@H](CCC(O)=O)C(O)=O
Molecular Formula
C13H15NO6S
Molecular Weight
313.33
References & Citations
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
CD45 / LCA (2B11 + PD7/26), CF568 conjugate, 0.1mg/mL
CD50 (ICAM-3) (101-1D2), CF594 conjugate, 0.1mg/mL
CD44 Standard (DF1485), CF405S conjugate, 0.1mg/mL
P21 / WAF1 (WA-1), CF640R conjugate, 0.1mg/mL
